Virtus Investment Advisers’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
– Sell
-432
Closed -$59.6K – 356
2023
Q4
$59.6K Hold
432
– – 0.04% 264
2023
Q3
$52.6K Sell
432
-50
-10% -$6.66K 0.04% 241
2023
Q2
$67.8K Hold
482
– – 0.05% 257
2023
Q1
$68.2K Hold
482
– – 0.05% 260
2022
Q4
$75.4K Hold
482
– – 0.05% 288
2022
Q3
$59K Buy
+482
New +$63.5K 0.03% 331
2018
Q1
– Sell
-596
Closed -$59K – 121
2017
Q4
$59K Sell
596
-33
-5% -$3.13K 0.01% 491
2017
Q3
$59K Sell
629
-66
-9% -$7.01K 0.01% 488
2017
Q2
$77K Sell
695
-16
-2% -$1.69K 0.01% 485
2017
Q1
$70K Buy
+711
New +$67.8K 0.01% 458
2016
Q4
– Sell
-3,076
Closed -$260K – 486
2016
Q3
$260K Buy
+3,076
New +$258K 0.02% 418

Other funds holding DGX

Virtus Investment Advisers's DGX Position: Q1 2024 in Review

Virtus Investment Advisers sold out of Quest Diagnostics (DGX) in Q1 2024, closing a stake of 432 shares — an estimated $59.6K sold.

Virtus Investment Advisers first reported a position in DGX in Q3 2016 and held it in 11 quarters. The position peaked at $260K in Q3 2016. 819 funds tracked by Wall St. Rank hold DGX as of Q1 2024.

  • Virtus Investment Advisers reported no remaining Quest Diagnostics position as of Q1 2024 after selling out during the quarter.
  • Virtus Investment Advisers sold 432 Quest Diagnostics shares in Q1 2024, an estimated $59.6K.
  • Virtus Investment Advisers first reported a position in Quest Diagnostics in Q3 2016 and held it in 11 quarters.
  • Virtus Investment Advisers's Quest Diagnostics position peaked at $260K in Q3 2016.
  • 819 funds tracked by Wall St. Rank held Quest Diagnostics as of Q1 2024.

Based on Virtus Investment Advisers's 13F filing for Q1 2024, filed 16 May 2024.